baber/WOPTO huggingface dataset:
Patent CN-100585326-C (CN)
Inventor: WUN-HYUK LEE
IPC: G01B7/16
Filed: 2007-11-19
Granted: 2010-01-27
Abstract: 本发明涉及轮胎变形量的非接触式测定方法，在从外部对轮胎带束层内部的钢丝帘线施加磁场，以使电流流过钢丝帘线内部后，在带束层的两末端形成磁偶极子，在带束层内部流过电流，整体构成谐振电路，可以通过上述谐振电路并采用通常的谐振频率计算式测定轮胎内部变形量。
Patent CN-100594066-C (CN)
Title: 中储式钢球磨制粉系统运行优化和节能控制方法
Inventor: JIANHONG LU
IPC: B02C25/00
Filed: 2008-04-25
Granted: 2010-03-17
Abstract: 中储式钢球磨制粉系统运行优化和节能控制方法，首先通过采集制粉系统运行数据，建立制粉系统制粉单耗与各运行参数之间的非线性神经网络模型，然后通过带约束条件的非线性优化，获得使制粉单耗较低的磨煤机入口负压、入口温度及磨煤机出口温度，以此作为控制系统的设定值；通过基于操作经验的给煤机转速智能控制、磨入口参数多变量解耦控制及智能倒风控制技术对整个制粉系统实施全局优化控制，确保制粉系统严格工作在最佳工况的附近，有效降低制粉单耗。本发明能有效抑制一次风压力在制粉系统启、停过程中的波动，杜绝由于倒风而引起的锅炉熄火等严重事故的发生，并有效减轻运行人员的操作强度。
Patent CN-100577370-C (CN)
Inventor: JIE ZHAO
IPC: B29C45/17
Filed: 2008-06-13
Granted: 2010-01-06
Abstract: 本发明涉及一种成型机产品取出机械手，包括一底座，底座上设有一双臂单驱动侧取机构、一单轴回转迎取机构以及一操控所述两机构的操作单元，通过双臂单驱动侧取机构将产品从成型机中取出，再配合单轴回转迎取机构将产品迎取并回转放置于专用的输送带上，而完成成型机中产品的取出动作，结构紧凑、操作简单，动作可靠，成本低。
Patent CN-100578124-C (CN)
Inventor: ZHIQIANG YU
IPC: F25D13/06
Filed: 2008-07-22
Granted: 2010-01-06
Abstract: 本发明公开了一种通过优化设计导风装置实现节能的节能型快速冻结装置，它具有库体(2)，库体(2)内设有传动装置(1)、均匀分布的冷风机(5)，冷风机(5)和传动装置(1)均通过电缆连接电控系统，传动装置(1)的上部设有上导风装置(3)，下方设有下导风装置(4)，其特征在于所述的上导风装置(3)具有均匀分布的导风槽(10)，导风槽(10)之间形成导风口(9)，中部的导风槽为均匀分布的∩型导风槽，两端的导风槽(10)设计成内倾斜吹风方式，左侧通道向右倾斜，右侧通道向左倾斜，使局部冷风向库体内部流动，下导风装置(4)具有均匀分布的U型导风槽(11)，导风槽(11)之间形成导风口(12)，本发明有效的减少冷风的损失，大大降低运行成本。
Patent CN-100557159-C (CN)
Title: 保温墙体混凝土骨料粒径选择浇筑方法
Inventor: LIANGSHAN QI
IPC: E04G21/06
Filed: 2008-08-08
Granted: 2009-11-04
Abstract: 本发明公开了一种保温墙体混凝土骨料粒径选择浇筑方法，它包括以下步骤：a、配制一种骨料粒径可分离混凝土，其中，混凝土的骨料粒径采用分段连续继配，粒径5～10mm的石子占石子总用量的30～35%，粒径10～30mm的石子占石子总用量的65～70%；b、使用一套混凝土输送设备将所述骨料粒径可分离混凝土送至浇筑工作面，利用混凝土骨料粒径选择分离装置对混凝土进行分离，让小粒径骨料混凝土进入厚度小的一侧模板，浇筑成保护墙体，让大粒径骨料混凝土进入厚度大的一侧模板，浇筑成剪力墙体，两侧同时浇筑；c、对两侧混凝土进行振捣，保证混凝土密实。本发明施工方便、容易操作、成本较低且浇筑效果好，适用于城镇各种形式的住宅办公建设，社会和经济效益良好。
Patent MX-3077-E (MX)
Title: Procedimiento para preparar esteres de acidos bencil iden amino - oxi alquil - carboxilicos
Inventor: DIJK JAN VAN
IPC: C07D209/12
Filed: 1971-06-08
Abstract: La presente invención se refiere a un procedimiento para preparar ésteres de ácidos bencilidenamino-oxialquil-carboxílicos, de la fórmula general. (VER FIGURA), y sus sales ácidas de adición, en donde A es azufre o el grupo -CHCH-; R1 es un halógeno, CF3 o CH3; R2 es un halógeno, mientras que cualquiera R1 ó R2 puede ser hidrógeno; R3 es hidrógeno o CH3-R4 es un grupo alquileno directo o derivado que contiene más de 5 átomos de carbono; m y n son 0 ó 1. y m + n es 1 ó 2; R5 es un grupo alquileno directo o derivado que contiene más de 6 átomos de carbono que puede substituírse por un grupo fenil, Y es un radical cíclico de hidrocarburo que contiene 5 ó 6 átomos de carbono o juntamente con el átomo de nitrógeno del grupo amino y R8 y/o R7 es un grupo monocíclico o cíclico, heterocíclico, que contiene a lo sumo 10 átomos de carbono o puede también contener un átomo de azufre y puede substituírse por metilo, R6 y R7 cada uno son hidrógeno o un grupo alquilo que contiene más de 8 átomos de carbono pero juntos no contienen más de 10 átomos, cuyos grupos, pueden substituírse por un grupo hidroxi, alcoxi o  aciloxi de la fórmula (VER FIGURA), en donde R6 puede además ser un grupo cicloalquilo que contienen de 3 a 8 átomos de carbono, un grupo fenilo, halogenofenilo, arilo o feniloloquilo que contiene más de 9 átomos de carbono un grupo piridil o un grupo acilo que contiene más de 10 átomos de carbono, mientras que R6 y R7 juntamente con el átomo de nitrógeno al cual están ligados, pueden formar un grupo monocíclico o bicíclico heterocíclico a lo sumo de 10 átomos de grupo, cuyo grupo puede además contener un átomo de  oxígeno o un segundo átomo de nitrógeno como un átomo de grupo, son producidos mediante la reacción en un disolvente inactivo a una temperatura entre la temperatura ambiente y el punto de ebullición del disolvente, de un compuesto de la fórmula (VER FIGURA), con un compuesto de la fórmula (VER FIGURA), en cuyas fórmulas los signos tienen los mismos significados que en la fórmula 1 y M un átomo de metal o un átomo de hidrógeno y que se caracteriza además en que la reacción es llevada a cabo en un solvente inerte si es necesario, en la presencia de un agente aglutinante ácido.
Patent MX-6051-E (MX)
Inventor: TIEN-SZU-LIU RICHARD
IPC: B01J13/02
Filed: 1979-08-03
Abstract: Coffee capsules are described, comprising a hardened shell of coffee and/or coffee substitute solids surrounding a droplet of coffee oil containing coffee aroma. They are made by contacting particles of an emulsion of coffee oil and aromatic coffee distillate with particles of instant coffee and/or coffee substitute powder. The capsules are added to instant coffee or an instant-coffee substitute.
Patent MX-2963-E (MX)
Title: Mejoras en un aparato para remover particulas solidas de combustibles que se encuentran en los gases de descarga de hornos de calcinacion de coque
Inventor: BYRNE HENRY JAMES
IPC: B01D49/00
Filed: 1975-07-03
Abstract: La presente invención se refiere a mejoras en un aparato para remover partículas sólidas de combustibles que se encuentran en los gases de descarga de hornos de calcinación de coque, para remoción y combustión de partículas de carbono atrapadas en una corriente de gas de desperdicio, que comprende una cámara de combustión esencialamente lineal, que tiene una recubrimiento refractario; caracterizadas en que la cámara de combustión tiene un primer pasaje substancialmente horizontal, el primer pasaje tiene una entrada de gas de descarga en un extremo del mismo y una pluralidad de entrada de inyección de aire en la región de la entrada de gas de descarga para permitir la inyección de aire para promover el mezclado completo de gases de descarga y aire, el primer pasaje se comunica en su extremo opuesto con un segundo pasaje dispuesto substancialmente paralelo con y debajo del primer pasaje, de modo que el gas que pasa desde el primer pasaje al segundo pasaje, sufra una inversión en dirección de flujo y "deslizamiento" consecuente de partículas sólidas atrapadas con relación al gas, el segundo pasaje tiene una salida de gas en el extremo opuesto a su comunicación con el primer pasaje.
Patent PT-1152792-E (PT)
Inventor: KASEVICH RAYMOND S
IPC: A61B18/18
Filed: 2000-02-08
Abstract: Medical systems and instruments which utilize microwave energy to provide heat treatment and diagnostic imaging of tissue are provided. One medical treatment system for treating tissue includes an antenna having a radiating element configured to transmit electromagnetic energy toward a desired area of the tissue and having an interior volume for receiving a heat exchange fluid, thereby changing the temperature proximal to the desired area of the tissue.
Patent PT-1198226-E (PT)
Inventor: VILLA ROBERTO
IPC: A61K47/38
Filed: 2000-06-08
Abstract: Controlled-release oral pharmaceutical compositions containing as active ingredient 5-amino-salicylic acid, comprising:   a) an inner lipophilic matrix consisting of substances with melting point below 90 DEG C in which the active ingredient is at least partly inglobated; b) an outer hydrophilic matrix in which the lipophilic matrix is dispersed; c) optionally other excipients.mp
Patent PT-1230401-E (PT)
Inventor: DONOVAN MICHAEL
IPC: C13B20/16
Filed: 2000-11-13
Abstract: A nanofiltration process for obtaining sucrose uses a feed syrup, such as molasses, that comprises sucrose and no less than about 2 % by weight invert sugars (on a dry solids basis). The nanofiltration produces a permeate and retentate. The nanofiltration permeate will comprise invert sugars that have passed from the feed through the nanofiltration membrane, and preferably will also comprise ash from the feed. The nanofiltration retentate has a higher concentration of sucrose and a lower concentration of invert sugars than the feed syrup. Sucrose can then be crystallized from the nanofiltration retentate. The reduction of the invert content in the syrup facilitates crystallization and thus enhances sucrose recovery.
Patent PT-1259769-E (PT)
Inventor: HORST DOERK
IPC: F28D5/00
Filed: 2001-02-06
Abstract: The invention relates to a device for producing cold water for the purpose of cooling rooms, especially for cooling surfaces (11) and coolers in the building equipment, especially for cool ceilings. The inventive device comprises a refrigeration machine (1) and an evaporative cooler (14) mounted upstream thereof through which liquid to be cooled and air flows. The cooling air flow of the evaporative cooler (14) can be exposed to water and the liquid to be cooled flows across a heat exchanger (23) or directly to a temporary storage (9) or directly to the consumer (11).
Patent PT-1495610-E (PT)
Title: Method and device for handling synchronization related information
Inventor: RAPAKKO JOUNI
IPC: H04L7/00
Filed: 2002-04-15
Abstract: SyncML allows synchronization to take place between a terminal device and a server device. To be able to understand each other the data transferred between a SyncML client and a SyncML server must be coded as a SyncML document. The coding or decoding/parsing of the SyncML document is done by the separate application components, respectively, that other end-user applications (e.g. a UI application) can use. It is not always wanted, advantageous or even possible to employ the SyncML coding/decoding feature, since it is subjected to several disadvantages. The present disclosure provides a concept to still use the synchronization related components for communicating synchronization data between the participating devices but without employing the coding/decoding component feature. The response of coding and decoding the synchronization data is transferred to corresponding end-user applications.
Patent PT-1417222-E (PT)
Title: Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
Inventor: CARUSO ARNALDO
IPC: A61K38/00
Filed: 2002-08-05
Abstract: New isolated polypeptides of the protein p17 of HIV are described, represented by the formula: NH2-X1-Gly-X2-X3-Leu-Asp-X4-Trp-Glu-X5-Ile-X6-Leu-Arg-COOH (SEQ ID NO:1) in which X1 is an amino acid residue selected from Ser and Arg; X2 is an amino acid residue selected from Gly, Glu and Ser; X3 is an amino acid residue selected from Glu, Lys, Asp and Arg; X4 is an amino acid residue selected from Arg, Ala, Lys, Thr, Ser, Glu, Asp and Gln; X5 is an amino acid residue selected from Lys, Arg and Ser; and X6 is an amino acid residue selected from Arg and Gln. These polypeptides, when administered to a subject, are able to evoke anti-p17 neutralizing antibodies and are therefore useful as vaccine or inoculum. Monoclonal and polycolonal anti-p17 antibodies which are able to neutralize the biological activity of this viral protein and to recognize its neutralization epitope in a specific manner are also described.
Patent PT-1500390-E (PT)
Inventor: HAKAN LOMRYD
IPC: A61K38/095
Filed: 2003-07-25
Abstract: The present invention relates to a novel pharmaceutical composition as a solid dosage form comprising desmopressin as a therapeutically active ingredient, and to a method for manufacturing thereof. The invention relates to a pharmaceutical composition as a solid dosage form comprising desmopressin, or a pharmaceutically acceptable salt thereof, as a therapeutically active ingredient together with a pharmaceutically acceptable excipient, diluent or carrier, or mixture thereof, wherein the pharmaceutical composition is composed of a compressed granulate and contains lubricant in an amount of from 0.05 to less than 0.50 percent by weight of said pharmaceutical composition.
Patent PT-1469755-E (PT)
Title: Automatically closing sunshade
Inventor: AMALRIC BERNARD
IPC: A45B25/22
Filed: 2003-01-27
Abstract: The sunshade (1) comprises an automatic closing mechanism (15) should it fall over, said mechanism (15) comprising an elongate sliding element (16, 36) wherein one part thereof protrudes above the corolla (5), said part being able to meet the ground should the parasol (1) fall over and being able to result in the sliding of said elongate element (16, 36), whereupon the releasable means (8, 10 ; 30, 31) for locking the sunshade in an open position can be released. According to the invention, said mechanism (15) comprises an elastic recall means (20) acting upon said elongate element (16, 36) in such a way that said elongate element (16, 36) is maintained in the sliding position wherein the elongate element (16, 36) does not act upon the releasable locking means (8, 10 ; 30, 31).
Patent PT-1616635-E (PT)
Title: Method for sorting containers
Inventor: OTTMANN MARC
IPC: B07C5/34
Filed: 2004-07-15
Abstract: The present invention concerns a method of sorting containers (9), fed arranged in bundles (8) according to a matrix which are examined for affiliation with a sort, removed from the bundles (8) and, separated by sort, and put into bundles (8) again.  The object of the invention, to create a method of the afore-mentioned type which allows the automatic sorting of a fairly large number of containers and/or bundles per unit of time without excessive financial outlay, is achieved by the method according to the invention comprising a first step consisting in the examination of all the containers contained in a bundle in view of the determination of their respective sort (A, B, C or D), a second step wherein the result of said first test of the containers (9) for affiliation with a sort (A, B, C or D) is used to control a first robot (13) in such a way that this robot removes all the containers (9) of all the sorts from the bundle (8) together and puts them according to their specific sort on separate conveyors (4), each said separate conveyor being assigned to a specific sort, which second step is followed by a transfer of the containers (9) by means of the respective conveyors on which they have been put to a collection table (15) on which they are stored until enough containers (9) of a sort (A, B, C or D) have constituted a full matrix, after which a second robot (16) removes all the containers (9) of said full matrix from the collection table (15) and puts them in a predetermined bundle (8).
Patent PT-1603731-E (PT)
Title: Method for continuously producing plastic tubes by biaxial drawing and a production line for carrying out said method
Inventor: PREVOTAT BERNARD
IPC: B29C48/32
Filed: 2004-03-03
Abstract: Method for continuous production of tubes of plastic material by biaxial drawing. Method for continuous production of tubes of plastic material by biaxial drawing comprises: (1) forming a rough shape (E) by extrusion; (2) adjusting (E) to the temperature of molecular orientation; (3) subjecting it to radial expansion by applying an internal fluid pressure (P), through two axially spaced shutters; and (4) ensuring calibration and cooling, while exerting an axial traction on the tube. The new feature is that a pressure (P1), opposing (P), is applied externally against the wall of (E) in at least one zone that is subjected to radial expansion. P1 is smaller than P, so does not prevent expansion, but is sufficient to ensure a controlled expansion so that material thickness is constant over a given circumference. An independent claim is also included for a production line for performing the new method.
Patent PT-2047270-E (PT)
Title: Stabilizing agents and capture ligands for use in assays measuring analyte concentrations
Inventor: LU WENYUAN
IPC: G01N33/53
Filed: 2007-07-20
Abstract: The present invention is related to compositions useful for the measurement of free or unbound analyte concentrations in a fluid. The present invention includes the use of capture ligands and stabilizing agents to improve the accuracy of analyte concentration assays. Methods and tools for using the present invention are also disclosed.
Patent PT-2118409-E (PT)
Title: Lock cylinder with wearing prevention means
Inventor: WALLBERG THOMAS
IPC: E05B15/06
Filed: 2008-02-05
Abstract: The invention relates to a lock cylinder (1) having a housing (2) and a cylinder core (4) which is mounted in a housing bore (3) and has a key channel (5) which can receive a key and has zones (7) of relatively hard material arranged on both sides of the key channel (5), in the vicinity of the mouth (6) of the key channel (5). In order to reduce wear, it is proposed that the zones of relatively hard material (7) are spaced apart from one another to such a small extent that right from the start, or following wear-induced abrasion of the key-channel wall (8), they form part of this key-channel wall.
Patent PT-2158092-E (PT)
Title: Thermal transfer printing
Inventor: HOWELL JEFFREY MICHAEL
IPC: B41F16/00
Filed: 2008-06-17
Abstract: Apparatus for thermal transfer printing of an image from a thermal retransfer sheet onto an article, includes heating means adapted to supply a flow of heated gas for causing dye transfer, and oscillating vane means for directing the heated gas in a direction transverse to the direction of flow, for distributing the heated gas over article(s) during dye transfer. Also disclosed is a method of printing an image, and the resulting printed article.
Patent PT-2313151-E (PT)
Title: Ear stimulator for producing a stimulation signal to an ear
Inventor: VOS GERRIT JOHANNIS DE
IPC: A61B7/00
Filed: 2009-06-18
Abstract: An electronic stimulation system to be worn in, behind or on a human ear having a casing; a detection device to sense breathing activity from a human being and to generate a detection signal; electronics within the casing and having a controller connected to the detection device to process the detection signal and generate a control signal when the controller has determined that the human being is in a state of developing apnoea; a stimulation device to receive the control signal from the electronics and to provide stimuli to one or more points of the human ear; wherein when the electronic stimulation system is worn in, behind or on the human ear, the stimulation device is pushed against a predetermined portion of the human ear.
Patent PT-2424538-E (PT)
Title: Use of allopurinol for the treatment of hand foot skin reaction
Inventor: RODEMER YOLANDA
IPC: A61K9/00
Filed: 2010-04-29
Abstract: Use of allopurinol or a pharmaceutically acceptable salt thereof for the treatment or prevention of Hand Foot Skin Reaction (HFSR) induced by Multitargeted Kinase (MKI) therapy. The allopurinol or its salt is administered topically to the affected areas, palms and soles, preferably in the form of a cream.
Patent PT-597349-E (PT)
Inventor: WILHELM VOLEJNIK DIPL ING
IPC: H04J3/06
Filed: 1993-11-02
Abstract: In the time-division multiplex method, a byte-wise alignment of the signals (P12) which are plesiochronous in a container (C4) is performed. Said signals are intermediately stored in separate regions of a buffer memory (4), output in the time-division multiplex operation, and converted into serial data signals (AP12) in parallel/serial converters (PSU1 ... PSU63). The frequency matching is performed individually for each transmitted plesiochronous signal (AP12.1 ... AP12.63) by a phase-regulating device (7). <IMAGE>
Patent PT-639079-E (PT)
Inventor: THOMPSON ROBERT C
IPC: A61P19/02
Filed: 1993-04-28
Abstract: The invention relates to methods for treating or preventing diseases that are IL-1 mediated diseases or TNF mediated diseases, including arthritis, septic shock, inflammatory bowel disease, ischemia injury, reperfusion injury, pulmonary fibrosis and adult respiratory distress syndrome. The method comprises administering to patients in need thereof therapeutically effective amounts of an IL-1 inhibitor and a TNF inhibitor. In a preferred embodiment, the IL-1 inhibitor is human recombinant IL-1ra and the TNF inhibitor is human recombinant 30kDa TNF inhibitor. The invention also relates to pharmaceutical compositions containing an IL-1 inhibitor and a TNF inhibitor useful in such methods.
Patent PT-667959-E (PT)
Inventor: VIGO-PELFREY CARMEN
IPC: C12N15/09
Filed: 1993-09-01
Abstract: Elevated levels of  beta AP in body fluids, such as blood and cerebrospinal fluid, is associated with the presence of a  beta AP-related condition in a patient, such as Alzheimer's Disease. Soluble  beta -amyloid peptide ( beta AP) is measured in biological fluids at very low concentrations, typically in the range from 0.1 ng/ml to 10 ng/ml. The measurement of  beta AP concentrations in animals or conditioned medium from cultured cells is used for drug screening, where test compounds are administered to the animals or exposed to the cultured cells and the accumulation of  beta AP in the animal or culture medium observed. <IMAGE>
Patent PT-695303-E (PT)
Inventor: OPFERKUCH WOLFGANG
IPC: A61K31/435
Filed: 1994-04-20
Abstract: PCT No. PCT/EP94/01218 Sec. 371 Date Oct. 20, 1995 Sec. 102(e) Date Oct. 20, 1995 PCT Filed Apr. 20, 1994 PCT Pub. No. WO94/24130 PCT Pub. Date Oct. 27, 19948-phenalkoxyimidazo[1,2-a]pyridinium salts are useful for controlling Helicobacter bacteria. Medicament compositions based on such compounds are prepared and used for the noted purpose.
Patent PT-721358-E (PT)
Inventor: POULSEN JENS ULRIK
IPC: A61M5/145
Filed: 1994-09-27
Abstract: In a displacement system for controlled infusion of a liquid from a cartridge comprising a tubular vessel (1), which is at a rear end closed by a piston (3) which may be forced by a piston rod (8) moving into the vessel (1) in the axial direction thereof to press out the liquid through an outlet (2) arranged at a front end of the vessel (1), the piston rod (8) is provided as a flexible incompressible construction which is by a piston rod guide (9) behind the rear end of the cartridge deflected away from the axis of this cartridge, preferably 180 DEG . The piston rod guide (9) has a guiding track comprising a curved part and linear parts at each end of the curved part ensuring that the piston rod is guided along a length (a) in the direction of the axis of the cartridge which length (a) is longer than the distance (b) between the two axes of the piston rod parts projecting from the piston rod guide. The guiding track is further elaborated to the very shape which the curved part of the piston rod will spontaneously adopt when its end portions are kept parallel.
Patent PT-773789-E (PT)
Title: Use of mhc xenoantigen in the manufacture of a medicament for the treatment of cancer
Inventor: TURIANO ANGELA
IPC: C07K1/12
Filed: 1994-12-22
Abstract: Allo-, iso- and xenoantigens, chosen from histocompatibility molecules obtained by extraction from homogenates of tissues or cells with Nonidet P40 or 1 N HClO<SUB>4</SUB>, are disclosed for use as a medicament for stimulation of the immune system of man and mammals, and in particular for cancer therapy.
Patent PT-771341-E (PT)
Inventor: AMON ALBERT
IPC: C09D11/30
Filed: 1995-07-18
Abstract: An ink which is to be used for high resolution continuous ink jet printing may also contain, in contrast to current knowledge, water insoluble colouring agents in dispersed form. The known problems associated with such inks stem from the additives which are necessary for the stabilisation of the ink, and from a badly adapted size distribution of the colouring agent particles. Thus, additives should be preferred whose average molecular weight is less than 20,000. With substances that are hydrogen bridge active, in particular that contain hydroxy or amino groups, this limit must be still lower, i.e. about 1,000. The particles of the colouring agent should have a size distribution wherein the colouring agent's total volume proportion of particles greater than 200 nm is less than about 10 %, and that of particles greater than 300 nm less than about 3 %.